Free Trial
LON:SUMM

Summit Therapeutics (SUMM) Share Price, News & Analysis

Summit Therapeutics logo

About Summit Therapeutics Stock (LON:SUMM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
20.50
20.50
52-Week Range
N/A
Volume
280,318 shs
Average Volume
382,504 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SUMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SUMM Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

SUMM Stock Analysis - Frequently Asked Questions

Summit Therapeutics PLC (LON:SUMM) issued its earnings results on Wednesday, June, 12th. The company reported ($3.00) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.00) by $1.00.

Shares of SUMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Summit Therapeutics investors own include Summit Therapeutics (SMMT), American Airlines Group (AAL), Acadia Healthcare (ACHC), Academy Sports and Outdoors (ASO), Diana Shipping (DSX), 2570 (JLF.L) (JLF) and National Fuel Gas (NFG).

Company Calendar

Last Earnings
6/12/2019
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drugs - Generic
Sub-Industry
N/A
Current Symbol
LON:SUMM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:SUMM) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners